Warning: The NCBI web site requires JavaScript to function. more...
Plasmodium vivax trophozoites insensitive to chloroquine.
Sharrock WW, Suwanarusk R, Lek-Uthai U, Edstein MD, Kosaisavee V, Travers T, Jaidee A, Sriprawat K, Price RN, Nosten F, Russell B.
Malar J. 2008 May 27;7:94.
Related citations
Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, Brockman A, Prayoga P, Sugiarto P, Cheng Q, Tjitra E, Anstey NM, Price RN.
Antimicrob Agents Chemother. 2008 Mar;52(3):1040-5. Epub 2008 Jan 7.
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
Price RN, Marfurt J, Chalfein F, Kenangalem E, Piera KA, Tjitra E, Anstey NM, Russell B.
Antimicrob Agents Chemother. 2010 Dec;54(12):5146-50. Epub 2010 Sep 27.
Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.
Kosaisavee V, Suwanarusk R, Nosten F, Kyle DE, Barrends M, Jones J, Price R, Russell B, Lek-Uthai U.
Exp Parasitol. 2006 Sep;114(1):34-9. Epub 2006 Mar 20.
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN.
PLoS One. 2007 Oct 31;2(10):e1089.
Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.
Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J.
Antimicrob Agents Chemother. 2003 Jan;47(1):170-3.
Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo.
Hamedi Y, Nateghpour M, Tan-ariya P, Tiensuwan M, Silachamroon U, Looareesuwan S.
Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):512-8.
[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.
Sante. 2008 Jan-Mar;18(1):43-7. French.
Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay.
Briolant S, Parola P, Fusaï T, Madamet-Torrentino M, Baret E, Mosnier J, Delmont JP, Parzy D, Minodier P, Rogier C, Pradines B.
Malar J. 2007 Apr 16;6:44.
The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.
Kaewpongsri S, Sriprawat K, Suwanarusk R, Kyle DE, Lek-Uthai U, Leimanis M, Lwin KM, Phyo AP, Zwang J, Russell B, Nosten F, Renia L.
Antimicrob Agents Chemother. 2011 Mar;55(3):1300-4. Epub 2010 Dec 28.
Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand.
Hamedi Y, Nateghpour M, Soonthornsata B, Tan-ariya P, Kojima S, Chindanond D, Looareesuwan S.
Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):435-7.
Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.
Lek-Uthai U, Suwanarusk R, Ruengweerayut R, Skinner-Adams TS, Nosten F, Gardiner DL, Boonma P, Piera KA, Andrews KT, Machunter B, McCarthy JS, Anstey NM, Price RN, Russell B.
Antimicrob Agents Chemother. 2008 Jul;52(7):2435-41. Epub 2008 Apr 28.
Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.
Druilhe P, Brasseur P, Blanc C, Makler M.
Antimicrob Agents Chemother. 2007 Jun;51(6):2112-6. Epub 2007 Mar 26.
An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine.
Tasanor O, Noedl H, Na-Bangchang K, Congpuong K, Sirichaisinthop J, Wernsdorfer WH.
Acta Trop. 2002 Jul;83(1):49-61.
In vitro interaction between artemisinin and chloroquine as well as desbutyl-benflumetol in Plasmodium vivax.
Kyavar L, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer G, Sirichaisinthop J, Wernsdorfer WH.
Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):62-9.
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S.
Antimicrob Agents Chemother. 2007 Apr;51(4):1172-8. Epub 2007 Jan 12.
Chloroquine resistant falciparum malaria among security forces personnel in the Northern Province of Sri Lanka.
Hapuarachchi HA, Dayanath MY, Abeysundara S, Bandara KB, Abeyewickreme W, de Silva NR.
Ceylon Med J. 2004 Jun;49(2):47-51.
Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.
Muhamad P, Ruengweerayut R, Chacharoenkul W, Rungsihirunrat K, Na-Bangchang K.
Malar J. 2011 Feb 16;10(1):44.
In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand.
Lux D, Prajakwong S, Kollaritsch H, Wernsdorfer G, Wernsdorfer WH.
Wien Klin Wochenschr. 2003;115 Suppl 3:50-4.
Plasmodium vivax susceptibility to ferroquine.
Leimanis ML, Jaidee A, Sriprawat K, Kaewpongsri S, Suwanarusk R, Barends M, Phyo AP, Russell B, Renia L, Nosten F.
Antimicrob Agents Chemother. 2010 May;54(5):2228-30. Epub 2010 Mar 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on